What it is
STANAG 2551 is the NATO standardization agreement by which participating nations commit to implement AMedP-7.4, Edition B, NATO's medical publication on deployable outbreak and incident investigation teams. The STANAG itself sets no medical or technical detail; it is the agreement, and the substance lives in AMedP-7.4. This is Edition 2, promulgated 24 November 2020, and it consolidates what were previously two separate agreements: it supersedes both STANAG 2551, Edition 1, of 13 November 2013, and STANAG 2529, Edition 2, of 1 June 2016.
What the STANAG agrees to
The document states its aim as responding to an interoperability requirement: describing the concept and minimum requirements for a nation, or a group of nations, to establish and deploy a Medical Deployable Outbreak and Incident Investigation Team (Med-DOIIT). Nations that ratify the STANAG agree to implement the standard it names: AMedP-7.4, Edition B. The STANAG names no other related documents. Its own content is a short cover: an aim, an agreement to implement AMedP-7.4, and the administrative mechanics of ratification, implementation and review. What a Med-DOIIT actually does, and the configurations it can take, is described in AMedP-7.4 itself, not repeated here.
How it binds
A STANAG binds a nation, not a supplier, and it binds through ratification rather than by existing. Nations are invited to examine their own ratification and advise NATO's Standardization Office of their intention, and national responses are recorded in the NATO Standardization Document Database (NSDD). The STANAG takes effect on receipt by participating nations and NATO bodies, and it records no single NATO Effective Date - each ratifying nation's own timeline governs. A supplier meets STANAG 2551 and AMedP-7.4 only when a contract or tasking says so; the STANAG is silent on industry entirely.
What implementation actually involves
The STANAG lists four considerations for implementing AMedP-7.4: medical planning built around a concept of operations for activating and supporting a Med-DOIIT, establishing a training programme for it, exercising its deployment, and contributing to NATO Defence Planning Programme audits. Allies and NATO bodies report implementation details through the same electronic reporting tool used for ratification. That is where the practical work lands: planning, training and exercising a capability over time, not a one-time technical change, and not something this cover describes beyond naming it.
Review and status
The STANAG is reviewed in accordance with AAP-03, NATO's own directive for producing standardization documents, and the result of that review is recorded in the NSDD. It names no review date of its own. It is a NATO non-classified document, free of charge and not sold by NATO or by us; the current edition, and any newer one, is listed in the NATO Standardization Document Database. It is supervised under NATO's medical standardization structure, and comments on it are directed to the NATO Standardization Office.
What the document does not cover
STANAG 2551 names no certification, audit or inspection regime, and no threshold or numeric requirement. It does not describe what a Med-DOIIT does, how it is put together, or how it carries out its work: that belongs to AMedP-7.4, which is where the concept, configurations and requirements actually sit. Anyone looking for that detail will not find it on this cover.